Physiologas, a home hemodialysis service, has secured funding from Hokuhoku Capital.

▤ Summary

Physiologas Technologies secured additional Series A funding from Hokuhoku Capital and individual investors. The company will use the capital to accelerate design, development, prototyping, and non-clinical testing of a home hemodialysis device and consumables. Its goal is to make at-home dialysis more practical, safer, and more widely available for patients with end-stage renal disease in Japan. The release also positions the product as a quality-of-life improvement that could reduce clinic visits and support social reintegration and employment.

$ Funding

▦ Linked Companies